Literature DB >> 20175846

Relationship between the distribution of pseudoxanthoma elasticum skin and mucous membrane lesions and cardiovascular involvement.

Atsushi Utani1, Miki Tanioka, Yosuke Yamamoto, Reiko Taki, Eri Araki, Hiroshi Tamura, Yoshiki Miyachi.   

Abstract

Pseudoxanthoma elasticum (PXE) primarily affects organs that are abundant in elastic fibers, such as the skin, eye and blood vessels, and may eventually cause loss of vision or cardiovascular disease (CVD). Because CVD is a potentially life-threatening complication, its early detection is important for improving the quality of life of PXE patients. To determine the relationship between the distribution of skin and mucous membrane lesions and the prevalence of CVD in patients with PXE, we examined 14 PXE cases who presented between 2004 and 2007. All patients had angioid streaks (AS) and positive pathological findings. The skin lesions in PXE patients are distributed discontinuously and thus the degrees of skin involvement were assessed by determining the presence or absence of PXE skin and mucous membrane lesions in six sites (oral mucosa, neck, periumbilical region, cubital fossa, axillae and inguinal regions). Each site was given a binary score (i.e. present = 1, absent = 0) irrespective of severity and the scores were summed to yield a total distribution score (potential range of 0-6). Four cases had PXE-associated CVD. Their mean distribution score was 5.7, which was significantly higher than the score of the cases without CVD (1.8) (P = 0.0049). There was also significant correlation between the high distribution score (P = 0.0053) as well as CVD (P = 0.029) with the maximum width of AS. A higher distribution score and the presence of oral mucosal lesions were associated with CVD. This scoring method may be useful for predicting the presence of CVD in PXE patients.

Entities:  

Mesh:

Year:  2010        PMID: 20175846     DOI: 10.1111/j.1346-8138.2009.00775.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  Oral warning signs of elastic pseudoxanthoma.

Authors:  Lara Passos Alvim; Thaís Izidoro Pires; Maria das Graças Afonso Miranda Chaves; Cynthia Savioli; Gisele Maria Campos Fabri
Journal:  Womens Health (Lond)       Date:  2016-09-15

2.  Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Haitao Guo; David W Chou; Dominic J Harrington; Leon J Schurgers; Sharon F Terry; Jouni Uitto
Journal:  Am J Pathol       Date:  2013-02-15       Impact factor: 4.307

3.  Clinical Characterization of Korean Patients with Pseudoxanthoma Elasticum and Angioid Streaks.

Authors:  Ki Won Jin; Kwangsic Joo; Se Joon Woo
Journal:  Genes (Basel)       Date:  2021-08-04       Impact factor: 4.096

4.  Calcification in dermal fibroblasts from a patient with GGCX syndrome accompanied by upregulation of osteogenic molecules.

Authors:  Yumi Okubo; Ritsuko Masuyama; Akira Iwanaga; Yuta Koike; Yutaka Kuwatsuka; Tomoo Ogi; Yosuke Yamamoto; Yuichiro Endo; Hiroshi Tamura; Atsushi Utani
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

5.  Autofluorescence Imaging of the Skin Is an Objective Non-Invasive Technique for Diagnosing Pseudoxanthoma Elasticum.

Authors:  Klára Farkas; Szabolcs Bozsányi; Dóra Plázár; András Bánvölgyi; Luca Fésűs; Pálma Anker; Sára Zakariás; Ilze Lihacova; Alexey Lihachev; Marta Lange; Tamás Arányi; Norbert M Wikonkál; Márta Medvecz; Norbert Kiss
Journal:  Diagnostics (Basel)       Date:  2021-02-08

6.  Pseudoxanthoma elasticum of the skin with involvement of the oral cavity.

Authors:  Flávia Sayuri Matsuo; Alceu Luiz Camargo Villela Berbert; Sônia Antunes de Oliveira Mantese; Adriano Mota Loyola; Sérgio Vitorino Cardoso; Paulo Rogério de Faria
Journal:  Case Rep Dent       Date:  2013-05-18

7.  The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.

Authors:  Georges Lefthériotis; Loukman Omarjee; Olivier Le Saux; Daniel Henrion; Pierre Abraham; Fabrice Prunier; Serge Willoteaux; Ludovic Martin
Journal:  Front Genet       Date:  2013-02-12       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.